ORKA orukatx.com: EV/Sales Multiple

Official company branding of orukatx.com (ORKA)

Oruka Therapeutics Inc (ORKA) is a young biotech firm with strong leadership and a transparent strategy, although its lack of profitability and startup stage create a high dependency on investment. The EV/Sales ratio confirms current volatility, while the 0.00 indicator points to a status of market anticipation. Business development relies on partnerships with clinics to create advanced treatments for skin diseases.

ORKA Oruka Pharma Company Value to Revenue (11/23/2025 - 11/20/2026)

Oruka Corp - analytical breakdowns and key metrics (ORKA)

- current quotes and average value forecast:
- company stock capitalization data:
- cash balance and cash flow data:
Fundamental company valuation:ORKA, orukatx.com
Manufactured products of Oruka Therapeutics, Inc.

The EV/Sales metric determines business value relative to sales volume, excluding the impact of debt load on the valuation. By analyzing the current EV/Sales level on the GURU.Markets platform, an investor sees the market consensus on asset value without considering leverage. The ratio measures the premium for future revenue growth. For Oruka Therapeutics Inc (ORKA), this indicator reflects expectations for breakthrough antibodies, while commercial success remains dependent on FDA verdicts.